{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:03:32Z","timestamp":1791925412116,"version":"4.3.4"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials Advances"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.msec.2021.112615","type":"journal-article","created":{"date-parts":[[2021,12,29]],"date-time":"2021-12-29T03:14:02Z","timestamp":1640747642000},"page":"112615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Enhanced activity of AZD5582 and SM-164 in rabies virus glycoprotein-lactoferrin-liposomes to downregulate inhibitors of apoptosis proteins in glioblastoma"],"prefix":"10.1016","volume":"133","author":[{"given":"Yung-Chih","family":"Kuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Jung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajendiran","family":"Rajesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msec.2021.112615_bb0005","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s13346-019-00679-2","article-title":"Delivery across the blood-brain barrier: nanomedicine for glioblastoma multiforme","volume":"10","author":"Jena","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.msec.2021.112615_bb0010","doi-asserted-by":"crossref","first-page":"eabc2511","DOI":"10.1126\/sciadv.abc2511","article-title":"Regulation of tumor immune suppression and cancer cell survival by CXCL1\/2 elevation in glioblastoma multiforme","volume":"7","author":"Hu","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.msec.2021.112615_bb0015","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.msec.2018.10.094","article-title":"Targeted delivery of etoposide, carmustine and doxorubicin to human glioblastoma cells using methoxy poly(ethylene glycol)-poly(\u03b5-caprolactone) nanoparticles conjugated with wheat germ agglutinin and folic acid","volume":"96","author":"Kuo","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.msec.2021.112615_bb0020","doi-asserted-by":"crossref","first-page":"7717","DOI":"10.1158\/0008-5472.CAN-05-0347","article-title":"Accumulation of p53 and reductions in XIAP abundance promote the apoptosis of prostate cancer cells","volume":"65","author":"Mohapatra","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.msec.2021.112615_bb0025","first-page":"1","article-title":"Antioxidant vitamins promote anticancer effects on low-concentration methotrexate-treated glioblastoma cells via enhancing the caspase-3 death pathway","volume":"00","author":"Yiang","year":"2021","journal-title":"Food Sic. Nutr."},{"key":"10.1016\/j.msec.2021.112615_bb0030","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13578-020-00521-0","article-title":"BIRC3 and BIRC5: multi-faceted inhibitors in cancer","volume":"11","author":"Frazzi","year":"2021","journal-title":"Cell Biosci."},{"key":"10.1016\/j.msec.2021.112615_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jtice.2020.05.011","article-title":"Biomaterial-based drug delivery systems used to improve chemotherapeutic activity of pharmaceuticals and to target inhibitors of apoptosis proteins","volume":"111","author":"Kuo","year":"2020","journal-title":"J. Taiwan Inst. Chem. Eng."},{"key":"10.1016\/j.msec.2021.112615_bb0040","first-page":"781","article-title":"Structural basis of caspase inhibition by XIAP: differential roles of the linker versus the BIR domain","volume":"14","author":"Huang","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.msec.2021.112615_bb0045","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1158\/1078-0432.CCR-13-0227","article-title":"Molecular pathways: targeting inhibitor of apoptosis proteins in cancer-from molecular mechanism to therapeutic application","volume":"20","author":"Fulda","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.msec.2021.112615_bb0050","doi-asserted-by":"crossref","first-page":"992","DOI":"10.4161\/cc.27880","article-title":"Distinctive effects of the cellular inhibitor of apoptosis protein c-IAP2 through stabilization by XIAP in glioblastoma multiforme cells","volume":"13","author":"Yang","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.msec.2021.112615_bb0055","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/416345a","article-title":"TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2","volume":"416","author":"Li","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.msec.2021.112615_bb0060","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1667\/RADE-20-00171.1","article-title":"SMAC mimetic\/IAP inhibitor birinapant enhances radiosensitivity of glioblastoma multiforme","volume":"195","author":"Cerna","year":"2021","journal-title":"Radiat. Res."},{"key":"10.1016\/j.msec.2021.112615_bb0065","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/35022514","article-title":"Structural and biochemical basis of apoptotic activation by Smac\/DIABLO","volume":"406","author":"Chai","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.msec.2021.112615_bb0070","doi-asserted-by":"crossref","first-page":"9897","DOI":"10.1021\/jm401075x","article-title":"Discovery of a novel class of dimeric Smac mimetics as potent IAP antagonists resulting in a clinical candidate for the treatment of cancer (AZD5582)","volume":"56","author":"Hennessy","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.msec.2021.112615_bb0075","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1158\/1535-7163.MCT-10-0864","article-title":"Therapeutic potential and molecular mechanism of a novel, potent, non-peptide, Smac mimetic SM-164 in combination with TRAIL for cancer treatment","volume":"5","author":"Lu","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.msec.2021.112615_bb0080","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1158\/1535-7163.MCT-10-0643","article-title":"Radiosensitization of head and neck squamous cell carcinoma by a SMAC-mimetic compound, SM-164, requires activation of caspases","volume":"4","author":"Yang","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.msec.2021.112615_bb0085","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jtice.2020.09.012","article-title":"Particulate systems for improving therapeutic efficacy of pharmaceuticals against central nervous system-related diseases","volume":"114","author":"Kuo","year":"2020","journal-title":"J. Taiwan Inst. Chem. Eng."},{"key":"10.1016\/j.msec.2021.112615_bb0090","series-title":"Liposomes. Methods in Molecular Biology","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/978-1-4939-6591-5_14","article-title":"Gadolinium-loaded polychelating polymer-containing tumor-targeted liposomes","volume":"1522","author":"Erdogan","year":"2017"},{"key":"10.1016\/j.msec.2021.112615_bb0095","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0927-7765(95)01198-R","article-title":"Molecular interactions between phospholipids and mangostin in a lipid bilayer","volume":"4","author":"Yoshida","year":"1995","journal-title":"Colloid Surf. B-Biointerfaces"},{"key":"10.1016\/j.msec.2021.112615_bb0100","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.addr.2008.08.005","article-title":"Active targeting schemes for nanoparticle system in cancer therapeutics","volume":"60","author":"Byme","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.msec.2021.112615_bb0105","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.msec.2017.12.029","article-title":"Targeted transport of nanocarriers into brain for theranosis with rabies virus glycoprotein-derived peptide","volume":"87","author":"Fu","year":"2018","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.msec.2021.112615_bb0110","doi-asserted-by":"crossref","first-page":"11808","DOI":"10.1039\/c2jm31675g","article-title":"Brain-targeting gene delivery using a rabies virus glycoprotein peptide modulated hollow liposome: bio-behavioral study","volume":"22","author":"Tao","year":"2012","journal-title":"J. Mater. Chem."},{"key":"10.1016\/j.msec.2021.112615_bb0115","article-title":"Efficient neuronal targeting and transfection using RVG and transferrin-conjugated liposomes","author":"dos Santos Rodrigues","year":"1734","journal-title":"Brain Res."},{"key":"10.1016\/j.msec.2021.112615_bb0120","first-page":"121","article-title":"Characterization of lactoferrin receptor in brain endothelial capillary cells and mouse brain","volume":"14","author":"Huang","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.msec.2021.112615_bb0125","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.nbd.2009.07.028","article-title":"Approaches to transport therapeutic drugs across the blood\u2013brain barrier to treat brain diseases","volume":"37","author":"Gabathuler","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.msec.2021.112615_bb0130","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijpharm.2014.12.070","article-title":"Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles","volume":"479","author":"Kuo","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.msec.2021.112615_bb0135","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.lfs.2005.05.085","article-title":"Pharmacokinetics and brain uptake of lactoferrin in rats","volume":"78","author":"Ji","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.msec.2021.112615_bb0140","first-page":"317","article-title":"Immunohistochemical detection of lactoferrin in human astrocytomas and multiforme glioblastomas","volume":"43","author":"Tuccari","year":"1999","journal-title":"Eur. J. Histochem."},{"key":"10.1016\/j.msec.2021.112615_bb0145","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.actbio.2019.01.065","article-title":"Optimized liposomes with transactivator of transcription peptide and anti-apoptotic drugs to target hippocampal neurons and prevent tau-hyperphosphorylated neurodegeneration","volume":"87","author":"Kuo","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.msec.2021.112615_bb0150","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jnoncrysol.2003.08.020","article-title":"Rigidity aspects of the glass transition","volume":"329","author":"Huerta","year":"2003","journal-title":"J. Non-Cryst. Solids"},{"key":"10.1016\/j.msec.2021.112615_bb0155","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/03639045.2012.668912","article-title":"Influence of lipid composition on the phase transition temperature of liposomes composed of both DPPC and HSPC","volume":"39","author":"Chen","year":"2013","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.msec.2021.112615_bb0160","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0927-7765(95)01198-R","article-title":"Molecular interaction between phospholipids and mangostin in a lipid bilayer","volume":"4","author":"Yoshida","year":"1995","journal-title":"Colloid Surf. B-Biointerfaces"},{"key":"10.1016\/j.msec.2021.112615_bb0165","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jcis.2012.01.035","article-title":"Stability of binary model membranes-prediction of the liposome stability by the langmuir monolayer study","volume":"372","author":"Szczes","year":"2012","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.msec.2021.112615_bb0170","first-page":"13","article-title":"Liposome: an overview","volume":"1","author":"Bhai","year":"2012","journal-title":"J. Pharm. Sci. Innov."},{"key":"10.1016\/j.msec.2021.112615_bb0175","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1039\/C3AN01684F","article-title":"ATR-FTIR spectroscopy as a tool to probe surface adsorption on nanoparticles at the liquid\u2013solid interface in environmentally and biologically relevant media","volume":"139","author":"Mudunkotuwa","year":"2014","journal-title":"Analyst"},{"key":"10.1016\/j.msec.2021.112615_bb0180","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.trac.2004.07.017","article-title":"The role of liposomes in analytical processes","volume":"24","author":"Gomez-Hens","year":"2005","journal-title":"Trac-Trend. Anal. Chem."},{"key":"10.1016\/j.msec.2021.112615_bb0185","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0378-5173(00)00442-7","article-title":"Polysaccharide coated liposomes for oral immunization development and characterization","volume":"203","author":"Venkatesan","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.msec.2021.112615_bb0190","first-page":"311","article-title":"In vitro release of hydrophilic and hydrophobic drugs from liposomal dispersions and gels","volume":"56","author":"Nounou","year":"2006","journal-title":"Acta Pharma."},{"key":"10.1016\/j.msec.2021.112615_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfa.2021.126166","article-title":"Double flow focusing microfluidic-assisted based preparation of methotrexate\u2013loaded liposomal nanoparticles: encapsulation efficacy, drug release and stability","volume":"614","author":"Aghaei","year":"2021","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"10.1016\/j.msec.2021.112615_bb0200","first-page":"265","article-title":"Effect of zeta potential on the properties of nano-drug delivery systems-a review (Part 2)","volume":"12","author":"Honary","year":"2013","journal-title":"Trop. J. Pharm. Res."},{"key":"10.1016\/j.msec.2021.112615_bb0205","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1248\/bpb.34.945","article-title":"Niosomes: a controlled and novel drug delivery system","volume":"34","author":"Rajera","year":"2011","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.msec.2021.112615_bb0210","doi-asserted-by":"crossref","first-page":"16502","DOI":"10.1021\/acsomega.0c00930","article-title":"Construction a long-circulating delivery system of liposomal curcumin by coating albumin","volume":"5","author":"Wei","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.msec.2021.112615_bb0215","doi-asserted-by":"crossref","first-page":"9897","DOI":"10.1021\/jm401075x","article-title":"Discovery of a novel class of dimeric SMAC mimetics as potent IAP antagonists resulting in a clinical candidate for the treatment of cancer (AZD5582)","volume":"56","author":"Hennessy","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.msec.2021.112615_bb0220","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1080\/00016489.2016.1242776","article-title":"AZD5582, an IAP antagonist that leads to apoptosis in head and neck squamous cell carcinoma cell lines and is eligible for combination with irradiation","volume":"137","author":"Kadletz","year":"2017","journal-title":"Acta Otolaryngol."},{"key":"10.1016\/j.msec.2021.112615_bb0225","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1158\/1535-7163.MCT-10-0643","article-title":"Radiosensitization of head and neck squamous cell carcinoma by a SMAC-mimetic compound, SM-164, requires activation of caspases","volume":"10","author":"Yang","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.msec.2021.112615_bb0230","first-page":"258","article-title":"In vitro radiosensitizing effects of temozolomide on U87MG cell lines of human glioblastoma multiforme, Iran","volume":"42","author":"Borhani","year":"2017","journal-title":"J. Med. Sci."},{"key":"10.1016\/j.msec.2021.112615_bb0235","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.neuint.2008.12.002","article-title":"A new blood\u2013brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes","volume":"54","author":"Nakagawa","year":"2009","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.msec.2021.112615_bb0240","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1177\/0271678X16630991","article-title":"In vitro models of the blood\u2013brain barrier: a overview of commonly used brain endothelial cell culture models and guidelines for their use","volume":"36","author":"Helms","year":"2016","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.msec.2021.112615_bb0245","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nature05901","article-title":"Transvascular delivery of small interfering RNA to the central nervous system","volume":"448","author":"Kumar","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.msec.2021.112615_bb0250","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1016\/j.biomaterials.2009.02.051","article-title":"Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles","volume":"30","author":"Liu","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.msec.2021.112615_bb0255","first-page":"1","article-title":"X-linked inhibitor of apoptosis protein \u2013 a critical death resistance regulator and therapeutic target for personalized cancer therapy","volume":"4","author":"Ausserlechner","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.msec.2021.112615_bb0260","doi-asserted-by":"crossref","first-page":"26895","DOI":"10.18632\/oncotarget.4822","article-title":"A novel small-molecule IAP antagonist, AZD5582, draws Mcl-1 down-regulation for induction of apoptosis through targeting of cIAP1 and XIAP in human pancreatic cancer","volume":"6","author":"Moon","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.msec.2021.112615_bb0265","first-page":"81","article-title":"Selective IAP inhibition results in sensitization of unstimulated but not CD40-stimulated chronic lymphocytic leukaemia cells to TRAIL-induced apoptosis","volume":"2","author":"Zhuang","year":"2014","journal-title":"Pharma. Res. Perspect."},{"key":"10.1016\/j.msec.2021.112615_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-018-0579-y","article-title":"Interferon-\u03b3 and smac mimetics synergize to induce apoptosis of lung cancer cells in a TNF\u03b1-independent manner","volume":"18","author":"Hao","year":"2018","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.msec.2021.112615_bb0275","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.brainres.2010.07.009","article-title":"MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax\/Bcl-2 ratio and caspase-3 activity","volume":"1352","author":"Shi","year":"2010","journal-title":"Brain Res."}],"container-title":["Biomaterials Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928493121007554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928493121007554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T21:10:54Z","timestamp":1760649054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928493121007554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":55,"alternative-id":["S0928493121007554"],"URL":"https:\/\/doi.org\/10.1016\/j.msec.2021.112615","relation":{},"ISSN":["2772-9508"],"issn-type":[{"value":"2772-9508","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced activity of AZD5582 and SM-164 in rabies virus glycoprotein-lactoferrin-liposomes to downregulate inhibitors of apoptosis proteins in glioblastoma","name":"articletitle","label":"Article Title"},{"value":"Biomaterials Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msec.2021.112615","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112615"}}